Filing Details
- Accession Number:
- 0001179110-18-008797
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-19 17:37:36
- Reporting Period:
- 2018-06-15
- Accepted Time:
- 2018-06-19 17:37:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1399519 | M David Weber | C/O Abiomed, Inc. 22 Cherry Hill Drive Danvers MA 01923 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 Par Value | Acquisiton | 2018-06-15 | 92,280 | $0.00 | 189,657 | No | 4 | A | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-06-15 | 20,533 | $440.65 | 169,124 | No | 4 | F | Direct | |
| Common Stock, $.01 Par Value | Acquisiton | 2018-06-18 | 33,500 | $10.03 | 202,624 | No | 4 | M | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-06-18 | 500 | $437.07 | 202,124 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-06-18 | 1,900 | $437.86 | 200,224 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-06-18 | 1,500 | $438.93 | 198,724 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-06-18 | 3,519 | $439.93 | 195,205 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-06-18 | 2,684 | $440.81 | 192,521 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-06-18 | 4,720 | $441.83 | 187,801 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-06-18 | 13,391 | $443.06 | 174,410 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-06-18 | 12,410 | $443.87 | 162,000 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-06-18 | 4,574 | $444.81 | 157,426 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-06-18 | 1,000 | $445.77 | 156,426 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-06-18 | 302 | $446.59 | 156,124 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2018-06-18 | 33,500 | $0.00 | 33,500 | $10.03 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2011-06-03 | 2020-06-03 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, $.01 Par Value | 15,497 | Indirect | By Trust |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | $22.44 | 2013-05-22 | 2022-05-22 | 0 | 25,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $23.15 | 2014-05-14 | 2023-05-14 | 0 | 23,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $21.55 | 2015-05-14 | 2024-05-14 | 0 | 15,000 | Direct |
| Common Stock | Stock Option (right to buy) | $66.25 | 2016-05-13 | 2025-05-13 | 0 | 10,000 | Direct |
| Common Stock | Stock Option (right to buy) | $99.62 | 2017-05-24 | 2026-05-24 | 0 | 7,000 | Direct |
| Common Stock | Stock Option (right to buy) | $134.51 | 2018-05-15 | 2027-05-15 | 0 | 8,000 | Direct |
| Common Stock | Stock Option (right to buy) | $381.97 | 2019-05-16 | 2028-05-16 | 6,500 | 6,500 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2022-05-22 | 0 | 25,000 | Direct |
| 2023-05-14 | 0 | 23,000 | Direct |
| 2024-05-14 | 0 | 15,000 | Direct |
| 2025-05-13 | 0 | 10,000 | Direct |
| 2026-05-24 | 0 | 7,000 | Direct |
| 2027-05-15 | 0 | 8,000 | Direct |
| 2028-05-16 | 6,500 | 6,500 | Direct |
Footnotes
- This option becomes exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
- Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
- Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
- Represents shares of common stock underlying performance-based awards of restricted stock units granted to this reporting person on June 15, 2015. One half of these restricted stock units vested on June 15, 2018 (into an equal number of shares of common stock) based on the issuer's achievement of a certain performance milestone with the remaining vesting on June 15, 2019 as long as the reporting person continues to be employed by the issuer on the vesting dates.
- Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards.
- Exercise of stock options pursuant to reporting owners 10b5-1 plan.
- Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $436.4400 and $437.4200. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $437.4600 and $438.3300. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $438.4500 and $439.3900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $439.4900 and $440.3600. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $440.4800 and $441.4300. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $441.4400 and $442.4300. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $442.5200 and $443.4100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $443.4400 and $444.4200. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $444.4400 and $445.3000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $445.4700 and $446.2300. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $446.4600 and $446.8100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Billionaire Hedge Funds
